Next-Generation Personalized Injection System

Publication ID: 24-11857708_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Personalized Injection System,” Published Technical Disclosure No. 24-11857708_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857708_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,708.

Summary of the Inventive Concept

A wearable, AI-powered injection device that integrates physiological parameter detection, genomic analysis, and real-time dosage adjustment for personalized medicine.

Background and Problem Solved

The original patent disclosed a supplementary device for attachment to an injection device, enabling dosage selection and detection. However, it was limited to mechanical coupling and lacked advanced features for personalized medicine. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to provide a more sophisticated and adaptive injection system.

Detailed Description of the Inventive Concept

The next-generation personalized injection system comprises a miniaturized injection module integrated with a sensor array to detect a patient's physiological parameters, such as glucose levels, blood pressure, and heart rate. The system is powered by an artificial intelligence algorithm that analyzes the patient's medical history, genomic data, and real-time physiological parameters to optimize the dosage and administration route. The system features interchangeable cartridges containing different medications, which are automatically detected and adapted to by the system. Additionally, the device includes a subcutaneous injection module with an integrated biosensor for continuous glucose level monitoring and automatic insulin administration. The handheld device also incorporates a microfluidic chip for real-time blood chemistry analysis and dosage adjustment.

Novelty and Inventive Step

The new claims introduce a paradigm shift in injection technology by integrating AI, genomic analysis, and real-time physiological parameter detection, making the original patent's mechanical coupling and dosage selection obsolete. The inventive concept's novelty lies in its ability to provide personalized medicine through advanced data analysis and adaptive dosage adjustment.

Alternative Embodiments and Variations

Alternative embodiments may include a smartphone app for remote monitoring and data analysis, a cloud-based platform for data storage and sharing, or a modular design allowing for easy upgrade and replacement of components. Variations may include different sensor arrays, AI algorithms, or medication cartridges tailored to specific medical conditions or patient populations.

Potential Commercial Applications and Market

The next-generation personalized injection system has significant commercial potential in the healthcare industry, particularly in the fields of diabetes management, personalized medicine, and pharmaceutical research. The market for such a system is vast, with potential applications in hospitals, clinics, and home care settings, as well as in the development of new medications and treatment protocols.

CPC Classifications

SectionClassGroup
A A61 A61M5/3155
A A61 A61M5/2033
A A61 A61M2005/3126
A A61 A61M2205/332
A A61 A61M2205/3327
A A61 A61M2205/3584
A A61 A61M2205/52
A A61 A61M2205/8206

Original Patent Information

Patent NumberUS 11,857,708
TitleDevice for attachment to an injection device
Assignee(s)Sanofi